Skip to main content
. Author manuscript; available in PMC: 2020 Nov 20.
Published in final edited form as: ACS Appl Bio Mater. 2020 Apr 22;3(5):2930–2939. doi: 10.1021/acsabm.9b01198

Figure 1. Scheme of intramyocardial delivery of antibody-coated MSCs.

Figure 1.

(a) Direct intramyocardial injection of antibody-coated MSCs and subsequent interaction of MSCs with inflamed endothelium. (b) Incorporation of inflammation-targeted antibody on MSCs through biotin-streptavidin affinity.